Scientists have genetically modified a strain of the herpes virus to act as a cancer-killing agent in humans. Findings from an initial human trial are encouraging, with the experimental treatment proving safe and promisingly effective.
“Viruses are one of humanity’s oldest enemies, as we have all seen over the pandemic,” explained Kristian Helen from the Institute of Cancer Research. “But our new research suggests we can exploit some of the features that make them challenging adversaries to infect and kill cancer cells.”
Image: The herpesvirus is designed to be injected into tumors and attract cancer-killing immune cellsDepositphotos